Teprenone for the prevention of low-dose aspirin-induced gastric mucosal injury in Helicobacter pylori-negative patients

© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group. Objectives: Low-dose aspirin is the standard treatment for the prevention of cardiovascular events in at-risk patients. We performed a randomized, placebo-controlled study to determine the efficacy of teprenone for primary p...

全面介紹

Saved in:
書目詳細資料
Main Authors: Taned Chitapanarux, Nirush Lertprasertsuke, Acharaporn Kongnak
格式: 雜誌
出版: 2020
主題:
在線閱讀:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85074031744&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/67955
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
機構: Chiang Mai University